financetom
VIV
financetom
/
Communication Services
/
VIV
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Telefônica Brasil S.A.VIV
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
13.88B
Revenue (ttm)
9.03B
Net Income (ttm)
897.01M
Shares Out
1.63B
EPS (ttm)
0.55
PE Ratio
15.47
Forward PE
13.21
Dividend
$0.45 (5.30%)
Ex-Dividend Date
Mar 25, 2025
Volume
174,970
Open
8.52
Previous Close
8.51
Day's Range
8.42 - 8.56
52-Week Range
7.47 - 10.41
Beta
0.30
Analysts
Buy
Price Target
9.97 (+17.71%)
Earnings Date
May 6, 2025
Description >

Telefônica Brasil S.A., together with its subsidiaries, operates as a mobile telecommunications company in Brazil.

Its fixed line services portfolio includes local, domestic long-distance, and international long-distance calls; and mobile portfolio comprises voice and broadband internet access through 3G, 4G, 4.5G, and 5G, as well as mobile value-added and wireless roaming services.

The company also offers data services, including broadband and mobile data services. In addition, it provides pay TV services through IPTV technologies; network services, such as rental of facilities; other services comprising internet access, private network connectivity, computer equipment leasing, extended service, caller identification, voice mail, cellular blocker, and others; wholesale services, including interconnection services to users of other network providers; and digital services, such as entertainment, cloud, and security and financial services.

Further, the company offers multimedia communication services, which include audio, data, voice and other sounds, images, texts, and other information, as well as sells devices, such as smartphones, broadband USB modems, and other devices.

Additionally, it provides telecommunications solutions and IT support to various industries, such as retail, manufacturing, services, financial institutions, government, etc. It markets and sells its solutions through own stores, dealers, retail and distribution channels, door-to-door sales, and outbound tele sales.

The company was formerly known as Telecomunicações de São Paulo S.A. - TELESP and changed its name to Telefônica Brasil S.A. in October 2011.

The company was incorporated in 1998 and is headquartered in São Paulo, Brazil.

Latest News >
AudioEye Gets $20 Million Loan Facility From Bridge Bank
AudioEye Gets $20 Million Loan Facility From Bridge Bank
Apr 1, 2025
05:59 PM EDT, 04/01/2025 (MT Newswires) -- AudioEye ( AEYE ) said Tuesday it secured a $20 million loan facility from Bridge Bank, a division of Western Alliance Bancorporation (WAL). The facility comprises a $12 million term loan, expected to repay the company's existing 2023 term loan and bolster its cash position, according to AudioEye ( AEYE ). It added...
Lithium Americas reaches final investment decision for Thacker Pass mine
Lithium Americas reaches final investment decision for Thacker Pass mine
Apr 1, 2025
April 1 (Reuters) - Lithium Americas ( LAC ) said on Tuesday it has reached a final investment decision (FID) for constructing the first phase of the Thacker Pass lithium mine in Nevada. The Thacker Pass project is a joint venture between Lithium Americas ( LAC ) and U.S. automaker General Motors ( GM ). Phase 1 of the project...
Where Zscaler Stands With Analysts
Where Zscaler Stands With Analysts
Apr 1, 2025
In the last three months, 19 analysts have published ratings on Zscaler ( ZS ) , offering a diverse range of perspectives from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings...
Inventiva Completes Enrollment in Phase 3 Study of Liver Treatment
Inventiva Completes Enrollment in Phase 3 Study of Liver Treatment
Apr 1, 2025
05:57 PM EDT, 04/01/2025 (MT Newswires) -- Inventiva ( IVA ) completed the enrollment in a phase 3 clinical trial of lanifibranor in patients with metabolic dysfunction-associated steatohepatitis, a liver disease. Enrollment targets were exceeded with 1,009 patients in the main cohort and 410 patients in the exploratory cohort, the company said Tuesday in a statement. Completion of enrollment in...
Copyright 2023-2025 - www.financetom.com All Rights Reserved